Related Experiment Video
Updated: Aug 2, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Cardiac Metabolism in Heart Failure and Implications for Uremic Cardiomyopathy
T Dung Nguyen1, P Christian Schulze1
1Department of Internal Medicine I, University Hospital Jena, Jena, Germany.
Insights
Chronic kidney disease (CKD) causes cardiovascular issues and a specific heart condition called uremic cardiomyopathy. Research suggests CKD heart metabolism shares similarities with heart failure, offering new therapeutic targets.
Area of Science:
- Nephrology
- Cardiology
- Metabolism
Background:
- Chronic kidney disease (CKD) elevates cardiovascular disease risk, including hypertension and coronary artery disease.
- CKD induces cardiac structural remodeling (hypertrophy, fibrosis) and functional impairments, defining uremic cardiomyopathy.
- Cardiac function is intrinsically linked to myocardial metabolism, with significant remodeling observed in heart failure.
Purpose of the Study:
- To review cardiac metabolic remodeling in heart failure.
- To extend this understanding to uremic cardiomyopathy in CKD patients.
- To identify potential overlapping and distinct metabolic mechanisms between heart failure and uremic cardiomyopathy.
Main Methods:
- Literature review of cardiac metabolism in heart failure.
- Analysis of recent findings on metabolism in uremic cardiomyopathy.
- Comparative assessment of metabolic remodeling in both conditions.
Main Results:
- Significant metabolic remodeling occurs in the failing heart.
- Emerging data suggest overlapping metabolic pathways in uremic cardiomyopathy and heart failure.
- Specific differences in cardiac metabolism between these conditions are yet to be fully elucidated.
Conclusions:
- Understanding similarities and differences in cardiac metabolism is crucial for uremic cardiomyopathy research.
- Identifying shared mechanisms may reveal novel therapeutic targets for both heart failure and CKD-related cardiac dysfunction.
- Further research into uremic heart metabolism is warranted to develop targeted therapies.
Abstract:
Chronic kidney disease is associated with an increased risk for the development and progression of cardiovascular disorders including hypertension, dyslipidemia, and coronary artery disease. Chronic kidney disease may also affect the myocardium through complex systemic changes, resulting in structural remodeling such as hypertrophy and fibrosis, as well as impairments in both diastolic and systolic function. These cardiac changes in the setting of chronic kidney disease define a specific cardiomyopathic phenotype known as uremic cardiomyopathy. Cardiac function is tightly linked to its metabolism, and research over the past 3 decades has revealed significant metabolic remodeling in the myocardium during the development of heart failure. Because the concept of uremic cardiomyopathy has only been recognized in recent years, there are limited data on metabolism in the uremic heart. Nonetheless, recent findings suggest overlapping mechanisms with heart failure. This work reviews key features of metabolic remodeling in the failing heart in the general population and extends this to patients with chronic kidney disease. The knowledge of similarities and differences in cardiac metabolism between heart failure and uremic cardiomyopathy may help identify new targets for mechanistic and therapeutic research on uremic cardiomyopathy.
More Related Videos
11:26Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer
Published on: February 13, 2019
12:24Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart
Published on: September 28, 2016
Related Concept Videos
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure Drugs: Diuretics
Cardiomyopathy VI: Nursing Management
Cardiomyopathy V: Interprofessional Care